JETEX LONDON TO WOW PRIVATE JET FLYERS
Jetex announces its first FBO in London, a top-tier destination for the brand’s robust international expansion
Dubai, United Arab Emirates, May 20, 2022 (GLOBE NEWSWIRE) -- London is a natural next destination for Jetex, an award-winning global leader in executive aviation, and it becomes the brand’s 35th international FBO location. Jetex entered in an agreement with Avia Solutions Group to operate the FBO at Hangar 510 at Biggin Hill Airport (EGKB/BQH).
The airport rightfully holds a pride of place in British History. Opened in 1916, the property was vacated by the Royal Air Force in 1992 and has operated as a privately-owned civilian airfield dedicated to business and civilian aviation ever since.
Today, it is recognized as a global center of excellence and the second private jet operation in the UK with 23% of London’s market share after Farnborough (31%) and ahead of Luton (22%). The airport typically connects flights to more than 750 destinations across over 70 countries, with over 90% of destinations being in Europe and 5% long haul.
Jetex London is conveniently located just 12 miles from Canary Wharf and 15 miles from Central London, with helicopter transfers taking passengers to and from the heart of the British capital in just six minutes, with limousine transfers taking less than 50 minutes.
The modern airport runway (1,806 meters) allows most aircraft to operate without payload or range restrictions, including non-stop transatlantic flights.
“We are pleased with our arrival in London. Jetex already has a strong presence in Continental Europe with a flagship private jet terminal at Paris Le Bourget, and the new flagship Jetex London is a natural evolution of our operations. Jetex passengers will enjoy a seamless travel experience complemented by the greatest levels of luxury hospitality, unseen before in the market.” said Adel Mardini, Founder & CEO of Jetex.
Jetex London will offer a suite of flagship services for passengers and crews traveling through the airport. It is a seamless, intuitive and dedicated route for Jetex customers to begin or end their journey in supreme comfort. The on-site U.K. Border Force and customs control will ensure that passengers and crew enjoy an efficient ground experience, while Jetex will also offer assistance with ground transport, hotel accommodation, catering, concierge services and much more.
”We are very delighted to welcome this new partnership with Jetex, one of the top names in executive aviation, and are looking forward to operating in Biggin Hill together. The airport is already one of the key points for Avia Solutions Group, as our subsidiary JETMS Completions is successfully running aircraft interior and exterior completions there. Thus, the partnership is opening even more opportunities for further business expansion as well as collaboration on future projects. We see great things ahead,” said Vygaudas Ušackas, Member of the Board of Directors at Avia Solutions Group.
“Jetex is a globally admired brand and we are proud to have the company join our ecosystem of aviation businesses here at London Biggin Hill Airport. We know Jetex will provide an excellent continuity of service and we are looking forward to seeing them thrive,” said Robert Walters, Commercial Director, London Biggin Hill Airport.
With natural materials, soft lighting, and floor-to-ceiling windows, Jetex London is designed to feel like a warm, contemporary space. The 1,900 sq.m. private terminal will include several supremely comfortable lounges of understated luxury designed with passenger privacy in mind, a cigar lounge, retail and entertainment areas, fully-equipped boardrooms, shower suites and much more. Crews will appreciate a full range of on-site recreational and flight support facilities.
Jetex London marks the company’s first entry into the United Kingdom as it looks forward to growing its operations in the market.
- END -
An award-winning global leader in executive aviation, Jetex is recognized for delivering flexible, best-in-class trip support solutions to customers worldwide. Jetex provides exceptional private terminals (FBOs), aircraft fueling, ground handling and global trip planning. The company caters to both owners and operators of business jets for corporate, commercial and personal air travel. To find out more about Jetex, visit www.jetex.com and follow us on Instagram, Twitter, Facebook, and LinkedIn.
About Avia Solutions Group:
Leaders in end-to-end capacity solutions for passenger and cargo airlines worldwide. The Group manages over 100 offices and production facilities globally and is significantly backed by the assets of over 7,000 highly skilled aviation professionals, serving more than 2,000 clients throughout Europe, Asia, North America, Australia, and worldwide.
AttachmentTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Report – ERYTECH’s Combined Shareholders’ Meeting On June 24, 202224.6.2022 22:05:00 CEST | Press release
REPORT –ERYTECH’S COMBINED SHAREHOLDERS’ MEETING ON JUNE 24, 2022 Cambridge, MA (U.S.) and Lyon (France), June24, 2022 – ERYTECH Pharma (Nasdaq& Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announcedthat its Annual General Meeting was held on Friday, June 24, 2022. At the meeting, all resolutions for which the Board of Directors recommended a vote in favor were adopted, including: Approval of the annual financial statements and consolidated financial statements for the year ended December 31, 2021;Allocation of the financial year's results;Approval of the statutory auditors’ special report on regulated agreements and commitments with related parties;Approval of the elements of total compensation and benefits paid or allocated for the year ended December 31, 2021, to Gil BEYEN, Chief Executive Officer and Jean-Paul KRESS, Chairman of the Board;Approval of the compens
Cleantech Building Materials: Results of Annual General Meeting24.6.2022 14:54:27 CEST | Press release
24 June 2022 CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN TICKER: CBM ISIN: GBOOBD1LVD21 CLEANTECH BUILDING MATERIALS PLC Results of Annual General Meeting The Annual General Meeting (“AGM”) of Cleantech Building Materials plc (“CBM” or the “Company”) was held in London earlier today, 24 June 2022. Details of the resolutions to be considered at the AGM were published in the Notice of AGM which was posted to Shareholders on 1 June 2022 and is available on the Company’s website: www.cbm-plc.com. All resolutions as set out in the Notice of AGM were duly passed without discussion. In particular, the following resolutions were passed at the AGM. The AGM resolved to authorise the directors of the Company to allot shares and grant rights to subscribe for, or convert any security, into shares. The directors of the Company sought authority for the purposes of section 551 of the Companies Act to exercise all the powers of the Company to allot shares and grant ri
Novartis receives positive CHMP opinion for Scemblix®, a novel treatment for adult patients with chronic myeloid leukemia24.6.2022 13:13:19 CEST | Press release
With unique STAMP mechanism of action, Scemblix could provide a new option for patients in Europe with chronic myeloid leukemia (CML) who have suffered intolerance or inadequate response with at least two prior tyrosine kinase inhibitor treatments1 Positive opinion based on data from pivotal Phase III ASCEMBL trial, showing a near doubling in major molecular response rate for patients treated with Scemblix® (asciminib) vs. Bosulif®* (bosutinib) (25.5% vs. 13.2%) and more than three times lower discontinuation rate due to adverse reactions (5.8% vs 21.1%) at 24 weeks1 CHMP recommendation comes after the approval of Scemblix by the US FDA and other countries’ regulatory authorities, potentially broadening access for more patients to Novartis transformative therapies in CML Basel, June 24, 2022 — Novartis today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting marketing au
Clariant’s shareholders approve all agenda items24.6.2022 11:30:00 CEST | Press release
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Integrated Report and Group Consolidated Financial Statements for fiscal year 2021 approvedGünter von Au reelected as Chairman of the Board of DirectorsThree new candidates join the Board of Directors: Ahmed Mohamed Alumar, Roberto César Gualdoni, Naveena ShastriConfirmed distribution of CHF 0.40 per shareKPMG confirmed as statutory auditor from 2022 MUTTENZ, JUNE 24, 2022 Clariant, a focused, sustainable, and innovative specialty chemical company, today held its 27th Annual General Meeting (AGM) where the shareholders approved all agenda items and resolutions as proposed by the Board of Directors. The AGM was held virtually, where shareholders were able to exercise their rights exclusively via the independent proxy. Overall, 698'945'298 shares or around 70.19 % of the share capital of Clariant were represented. Günter von Au was reelected as Chairman of the Board of Directors. Additionally, three new members were voted to join by a large majo
Cool Company Ltd. – Mandatory Notification Of Trade24.6.2022 11:01:19 CEST | Press release
EPS Ventures Ltd., close associate of Cyril Ducau, Chair of the Board of Cool Company Ltd. (the “Company”), has on 23 June 2022 acquired 7,865 shares in the Company at a price of NOK 90.274882 per share. Following the transaction, EPS Ventures Ltd. holds a total of 15,591,218 shares in the Company, equivalent to 38.97% of the Company’s shares. Please see the attached notification form in accordance with the Market Abuse Regulation article 19. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment Primary insider notification form